Kidney Patients' hidden danger: can common anemia pill fight deadly muscle loss?
NCT ID NCT07162090
Summary
This study is testing whether a medication called roxadustat, currently used to treat anemia in kidney patients, can also help prevent or reduce muscle loss in people on dialysis. Researchers will compare roxadustat against standard anemia treatment in 60 dialysis patients who already have muscle weakness. The goal is to see if this existing drug might offer a dual benefit for this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.